Given a growing body of evidence about adverse health outcomes associated with prenatal cannabis use, findings underscore the importance of patient-provider communication and messaging about safe alternatives to cannabis use during pregnancy.
Skelton et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: